Concert Pharmaceuticals Inc (CNCE) is around the top of the Biotechnology industry according to InvestorsObserver. CNCE received an overall rating of 79, which means that it scores higher than 79 percent of all stocks. Concert Pharmaceuticals Inc also achieved a score of 94 in the Biotechnology industry, putting it above 94 percent of Biotechnology stocks. Biotechnology is ranked 54 out of the 148 industries.
CNCE has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on CNCE!